JAAD Case Reports (Apr 2022)

Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab

  • Rosanne Ottevanger, MD,
  • Rutger C. Melchers, MD,
  • Koen D. Quint, MD, PhD

DOI
https://doi.org/10.1016/j.jdcr.2022.02.003
Journal volume & issue
Vol. 22
pp. 34 – 37

Abstract

Read online

No abstracts available.

Keywords